Clinical Trial Update: Biomarkers of Prednisolone Treatment (P05888) [NA]

View source ↗

Summary

This clinical trial evaluating biomarkers of prednisolone treatment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose Intolerance
• Hyperglycemia
• Insulin Resistance

Drugs mentioned

• Prednisolone (Prednisolone)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Insulin Resistance, Hyperglycemia | NA | Status: COMPLETED